In this issue:
Sulfonylureas added to or replacing metformin for type 2 diabetes
First trimester metformin exposure and risk of congenital anomalies
Diabetes prevalence in Australia
Empagliflozin in type 2 diabetes after CABG
Evaluation of a novel MetAP2 inhibitor
Sitagliptin vs. dapagliflozin in inadequately controlled type 2 diabetes with mild renal impairment
Impact of acute hyperglycaemia on exercise performance in type 1 diabetes
Case series of immunotherapyassociated diabetes
Vildagliptin added to insulin in type 1 diabetes mellitus
Metformin ±insulin and β-cell function in youth with IGT/recent type 2 diabetes
Please login below to download this issue (PDF)